Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Citation
The Anti-GM Food Circus Rolls Through Connecticut
From the American Council on Science and Health’s “Health Facts and Fears”: But as Gregory Conko, a senior fellow at the Competitive Enterprise…
Op-Eds
Shoppers already have a choice regarding biotech foods
Consumers increasingly base food purchasing decisions on individual preferences about product content. For many, this means a focus on nutrition or fat. Others care more…
Op-Eds
How is the FDA Really Doing?
I read with interest—and mounting skepticism—Patricia Dimond’s Insight & Intelligence™ piece about FDA, “FDA New Drug Approvals in 2011 Outpace…
Citation
Seeking Solution to “Incredibly Complex” Issue of Drug Shortages
Citation
Can Brand Makers Be Sued for Generic Drug Injuries?
Trib Live